SA 16 - Novel therapies require novel imaging: radiologists face cellular therapies, antibodies & Co.

This session is about the requirements diagnostic imaging has to meet in order to support novel oncologic therapies sufficiently. We will briefly cover the spectrum of novel therapeutic approaches and potentially complicating/challenging imaging and discuss the specificities for image-based therapy monitoring and imaging patterns of adverse therapy effects using CT, MRI, and hybrid imaging.